Lentivirus Tau (P301S) expression in adult amyloid precursor protein (APP)-transgenic mice leads to tangle formation

被引:12
|
作者
Osinde, M. [4 ]
Clavaguera, F. [2 ]
May-Nass, R. [4 ]
Tolnay, M. [2 ]
Dev, K. K. [1 ,3 ,4 ]
机构
[1] Natl Univ Ireland Univ Coll Cork, Dept Anat, Cork, Ireland
[2] Univ Basel, Inst Pathol, Basel, Switzerland
[3] Natl Univ Ireland Univ Coll Cork, Biosci Inst, Cork, Ireland
[4] Nova Pharma, Novartis Inst BioMed Res, Dept Neurosci, Basel, Switzerland
基金
瑞士国家科学基金会;
关键词
Alzheimer's disease; amyloid precursor protein; lentivirus; neurofibrillary tangles; Tau protein;
D O I
10.1111/j.1365-2990.2008.00936.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Aims: In this study, we aimed to investigate the interaction between amyloid- and Tau-associated pathologies to gain further insights into the development of Alzheimer's disease. We examined the formation of neurofibrillary tangles (NFT) in adult mouse brain without the prior overexpression of Tau at embryonic or early post-natal stages to dissociate any developmental mechanisms. Methods: Lentivirus technology was used to examine the effects of overexpressing mutant Tau-P301S in the adult mouse brains of both wild-type and amyloid precursor protein (APP)-transgenic mice. Results: We find that injection of lentivirus Tau-P301S into the hippocampus of adult wild-type mice increases levels of hyperphosphorylated Tau, as early as 3 months post injection. However, no NFT are found even after 13 months of Tau expression. In contrast, the overexpression of Tau-P301S in adult APP-transgenic animals results in the formation of Gallyas-stained NFT. Conclusions: Our current findings are the first to show that overexpression of Tau-P301S in adult mice overexpressing APP, but not wild-type mice, leads to enhanced Tau-related pathology.
引用
收藏
页码:523 / 531
页数:9
相关论文
共 50 条
  • [31] Cryo-EM structures of tau filaments from the brains of mice transgenic for human mutant P301S Tau
    Schweighauser, Manuel
    Murzin, Alexey G.
    Macdonald, Jennifer
    Lavenir, Isabelle
    Crowther, R. Anthony
    Scheres, Sjors H. W.
    Goedert, Michel
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2023, 11 (01)
  • [32] Contribution of endogenous antibodies to learning deficits and astrocytosis in human P301S mutant tau transgenic mice
    van der Hoven, Julia
    van Hummel, Annika
    Przybyla, Magdalena
    Asih, Prita R.
    Gajwani, Mehul
    Feiten, Astrid F.
    Ke, Yazi D.
    Ittner, Arne
    van Eersel, Janet
    Ittner, Lars M.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [33] Olfactory deficit is associated with mitral cell dysfunction in the olfactory bulb of P301S tau transgenic mice
    Li, Shanshan
    Li, Weiyun
    Wu, Xuewei
    Li, Jing
    Yang, Jing
    Tu, Chunlong
    Ye, Xuesong
    Ling, Shucai
    BRAIN RESEARCH BULLETIN, 2019, 148 : 34 - 45
  • [34] TREM2 modifies microglial phenotype and provides neuroprotection in P301S tau transgenic mice
    Jiang, Teng
    Zhang, Ying-Dong
    Chen, Qi
    Gao, Qing
    Zhu, Xi-Chen
    Zhou, Jun-Shan
    Shi, Jian-Quan
    Lu, Huan
    Tan, Lan
    Yu, Jin-Tai
    NEUROPHARMACOLOGY, 2016, 105 : 196 - 206
  • [35] Locus Coeruleus Ablation Exacerbates Cognitive Deficits, Neuropathology, and Lethality in P301S Tau Transgenic Mice
    Chalermpalanupap, Termpanit
    Schroeder, Jason P.
    Rorabaugh, Jacki M.
    Liles, L. Cameron
    Lah, James J.
    Levey, Allan I.
    Weinshenker, David
    JOURNAL OF NEUROSCIENCE, 2018, 38 (01): : 74 - 92
  • [36] Novel Behavioural Characteristics of Male Human P301S Mutant Tau Transgenic Mice - A Model for Tauopathy
    Watt, Georgia
    Przybyla, Magdalena
    Zak, Valeria
    van Eersel, Janet
    Ittner, Arne
    Ittner, Lars M.
    Karl, Tim
    NEUROSCIENCE, 2020, 431 : 166 - 175
  • [37] Synapse loss is an early pathological manifestation in a tauopthy model, P301S mutant tau transgenic mice
    Yoshiyama, Y
    Zhang, B
    Higuchi, M
    Trojanowski, JQ
    Lee, VM
    NEUROBIOLOGY OF AGING, 2004, 25 : S240 - S240
  • [38] Different modes of synaptic and extrasynaptic NMDA receptor alteration in the hippocampus of P301S tau transgenic mice
    Alfaro-Ruiz, Rocio
    Aguado, Carolina
    Martin-Belmonte, Alejandro
    Esther Moreno-Martinez, Ana
    Merchan-Rubira, Jesus
    Hernandez, Felix
    Avila, Jesus
    Fukazawa, Yugo
    Lujan, Rafael
    BRAIN PATHOLOGY, 2023, 33 (01)
  • [39] Behavioral deficit, oxidative stress, and mitochondrial dysfunction precede tau pathology in P301S transgenic mice
    Dumont, Magali
    Stack, Cliona
    Elipenahli, Ceyhan
    Jainuddin, Shari
    Gerges, Meri
    Starkova, Natalia N.
    Yang, Lichuan
    Starkov, Anatoly A.
    Beal, Flint
    FASEB JOURNAL, 2011, 25 (11): : 4063 - 4072
  • [40] Antileukotriene therapy by reducing tau phosphorylation improves synaptic integrity and cognition of P301S transgenic mice
    Giannopoulos, Phillip F.
    Chiu, Jian
    Pratico, Domenico
    AGING CELL, 2018, 17 (03)